TapewireFind a company

person · Reporting owner

EHRLICH JASON

Disclosed activity across 1 company

Tapewire entity
111881
SEC CIK
0001754049

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Kodiak Sciences Inc.KOD · Entity 4388See RemarksJune 24, 2023June 27, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Kodiak Sciences Inc.

Report date June 24, 2023 · Filed June 27, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23Direct207,500 Reported balance After 2023-06-24 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500

F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 510 $89.06 $45,418.46
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,577

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $88.81 to $89.78, inclusive.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 404 $88.17 $35,619.27
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,087

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $87.66 to $88.40, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 5,258 $10.29 $54,104.82
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2021 Filed Aug 13, 2021 22:45 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantRestricted Stock Units · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-051487 · doc4.xml · derivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock.

F3 · derivative.exercise_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F3 · derivative.expiration_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
August 12, 2021 Filed Aug 13, 2021 22:45 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $88.21 $0.00
Disclosure

SEC source: 0001209191-21-051487 · doc4.xml · derivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-08-12

F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after the Vesting Commencement Date (June 30, 2021); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
July 20, 2021 Filed Jul 22, 2021 20:37 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 4,716 $86.52 $408,035.39
Disclosure

SEC source: 0001209191-21-047756 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,233

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $86.09 to $86.89, inclusive.

Read SEC document
July 20, 2021 Filed Jul 22, 2021 20:37 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,234 $85.76 $191,588.73
Disclosure

SEC source: 0001209191-21-047756 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,949

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $85.085 to $86.085, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:38 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 845 $86.07 $72,728.56
Disclosure

SEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,183

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $85.895 to $86.16, inclusive.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:38 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 3,359 $85.45 $287,030.24
Disclosure

SEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,028

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $84.85 to $85.77, inclusive.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:38 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,884 $84.39 $158,999.24
Disclosure

SEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,387

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $83.82 to $84.765, inclusive.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:38 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 387 $83.39 $32,273.75
Disclosure

SEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,271

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $82.735 to $83.66, inclusive.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:38 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 475 $82.22 $39,053.41
Disclosure

SEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,658

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $81.615 to $82.605, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
June 15, 2021 Filed Jun 15, 2021 23:06 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,147 $84.75 $97,208.25
Disclosure

SEC source: 0001209191-21-040741 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,968

F3 · kind: The sale was made to cover tax withholding obligations in connection with vesting and settlement of 1/4th of the Reporting Person's performance-based RSU granted on December 30, 2019.

Read SEC document
June 15, 2021 Filed Jun 18, 2021 01:26 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 3,619 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-041809 · doc4.xml · derivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,857

Underlying: Common Stock · 3,619 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F3 · derivative.exercise_date: One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date.

F3 · derivative.expiration_date: One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date.

Read SEC document
June 15, 2021 Filed Jun 18, 2021 01:26 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,454 $80.90 $117,624.24
Disclosure

SEC source: 0001209191-21-041809 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,133

F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
June 15, 2021 Filed Jun 18, 2021 01:26 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 3,619 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-041809 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 23:06 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 2,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040741 · doc4.xml · derivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,700

Underlying: Common Stock · 2,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F4 · derivative.expiration_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 23:06 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantRestricted Stock Units · Derivative 11,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040741 · doc4.xml · derivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,600

Underlying: Common Stock · 11,600 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F4 · derivative.expiration_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 23:06 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantStock Option (Right to Buy) · Derivative 18,450 $0.00 Strike: $73.51 $0.00
Disclosure

SEC source: 0001209191-21-040741 · doc4.xml · derivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,450

Underlying: Common Stock · 18,450 shares

Expires 2029-12-29

F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 23:06 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 2,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-040741 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,115

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F2 · balance_after: Includes 54 shares acquired under the 2018 Employee Stock Purchase Plan on May 31, 2021.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 397 $82.53 $32,764.41
Disclosure

SEC source: 0001209191-21-035389 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,161

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $82.45 to $82.80, inclusive.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,490 $81.77 $121,841.77
Disclosure

SEC source: 0001209191-21-035389 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,558

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $81.365 to $82.36, inclusive.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 5,063 $80.85 $409,318.24
Disclosure

SEC source: 0001209191-21-035389 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,048

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $80.36 to $81.34, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
May 12, 2021 Filed May 14, 2021 21:22 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 1,889 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001209191-21-032823 · doc4.xml · derivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,793

Underlying: Common Stock · 1,889 shares

Expires 2028-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: One-sixtieth of the shares subject to the option vested on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
May 12, 2021 Filed May 14, 2021 21:22 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 5,379 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-032823 · doc4.xml · derivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,546

Underlying: Common Stock · 5,379 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
May 12, 2021 Filed May 14, 2021 21:22 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 1,889 $10.00 $18,890.00
Disclosure

SEC source: 0001209191-21-032823 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2021 Filed May 14, 2021 21:22 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 5,379 $10.29 $55,349.91
Disclosure

SEC source: 0001209191-21-032823 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,222

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · derivative · entry 8

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,925

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 182 $114.97 $20,925.07
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 7

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,843

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $114.68 to $115.33, inclusive.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 595 $113.73 $67,667.15
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 6

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,025

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $113.365 to $114.06, inclusive.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 669 $112.15 $75,029.82
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $111.88 to $112.58, inclusive.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 3,650 $111.31 $406,276.76
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,289

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $110.87 to $111.845, inclusive.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 621 $110.37 $68,541.38
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,939

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $109.845 to $110.84, inclusive.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,233 $109.33 $134,808.95
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,560

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $108.82 to $109.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 21:07 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-022881 · doc4.xml · derivative · entry 6

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,875

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 21:07 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 206 $133.38 $27,477.10
Disclosure

SEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,843

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $133.37 to $133.46, inclusive.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 21:07 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 672 $132.57 $89,086.37
Disclosure

SEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,049

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $132.165 to $132.71, inclusive.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 21:07 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 4,088 $131.71 $538,434.57
Disclosure

SEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,721

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $131.09 to $132.08, inclusive.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 21:07 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,984 $130.49 $258,896.13
Disclosure

SEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,809

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $130.04 to $130.94, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 21:07 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 22:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-018320 · doc4.xml · derivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,825

Underlying: Common Stock · 12,500 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 22:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 12,500 $10.29 $128,625.00
Disclosure

SEC source: 0001209191-21-018320 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · derivative · entry 8

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,325

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 413 $129.18 $53,349.61
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 7

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,343

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $128.75 to $129.45, inclusive.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,827 $127.34 $232,650.36
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 6

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,756

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $126.99 to $127.92, inclusive.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,611 $125.97 $202,940.73
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,583

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $125.67 to $126.628, inclusive.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,150 $124.92 $268,573.92
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,194

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $124.47 to $125.32, inclusive.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 687 $123.56 $84,888.61
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,344

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $123.28 to $124.20, inclusive.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:44 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 262 $122.00 $31,963.66
Disclosure

SEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,031

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $121.86 to $122.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.